Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The North Yorkshire Council
DL7 8AD
County Hall, Racecourse Lane
Northallerton
DL78AD
UK
Contact person: Caroline Reeves
E-mail: procurement@northyorks.gov.uk
NUTS: UKE22
Internet address(es)
Main address: https://www.northyorks.gov.uk
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
General public services
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Public Health Medicines Optimisation Service
Reference number: 776-NYC-HA
II.1.2) Main CPV code
85149000
II.1.3) Type of contract
Services
II.1.4) Short description
Public Health Medicine Optimisation and Advisory Service (PHMOAS - the Services ) will provide up to date medicines advice and guidance to the Council.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
30 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKE2
Main site or place of performance:
North Yorkshire
II.2.4) Description of the procurement
The Public Health Medicine Optimisation and Advisory Service (PHMOAS - the Services ) will provide up to date medicines advice and guidance to the Council , to ensure the safe and effective use of medicines across our services, and to support delivery of our statutory responsibilities. Through the provision of pharmaceutical advice from a NHS Band 8b pharmacist, and supporting workforce to maintain the provision of a prescribing dashboard.
The contract will be in place between 01/07/2026 to 30/06/2027 for a period of 12 months.
This notice is confirmation of an award having been made using the Provider Selection Regime Urgent Award Process.
II.2.5) Award criteria
Quality criterion: PSR Basic Selection Criteria
/ Weighting: 100
Price
/ Weighting:
0%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the Directive
Explanation
Termination of the existing Public Health Medicines Service contract is required due to significant and unforeseen structural changes, resulting in the imminent loss of service provision by the supplier.
The loss of pharmaceutical expertise presents a risk to continuity, legality, and patient safety, and continued reliance on the current provider is therefore not viable or proportionate and a Direct Award is essential to maintain continuity of service. Sufficient time was not available for alternative arrangements via competition. The urgent Direct Award is for a short time period, until new arrangements are put in to place.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
Lot No: 0
Contract No: 776
Title: Public Health Medicines Optimisation Service
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/07/2026
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received by electronic means: 0
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
PHARMACEUTICAL HEALTH CONSULTANTS LIMITED.
17292181
9 Brighouse Road, Middlesbrough, North Yorkshire, England
Middlesborough
TS2 1RT
UK
NUTS: UKE2
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 30 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.
Termination of the existing Public Health Medicines Service contract is required due to significant and unforeseen structural change, resulting in the imminent loss of service provision by the supplier.
Therefore, the contracts were awarded using the urgent award procedure.
VI.4) Procedures for review
VI.4.1) Review body
High Court of England and Wales
The Strand
London
UK
VI.5) Date of dispatch of this notice
01/07/2026